Antibodies
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q3 | 46.4% | 0.906 | Q2 | 81.2% |
| 2024 | 2.7 | Q3 | 39.7% | 0.949 | Q2 | 82.8% |
| 2023 | 3.0 | Q3 | 37.8% | 1.115 | Q1 | 88.0% |
| 2022 | 4.7 | 56.3% | 1.697 | Q1 | 94.4% | |
| 2021 | — | 14.6% | 0.614 | Q2 | 73.5% | |
| 2020 | — | — | 0.112 | Q4 | 6.4% | |
| 2019 | — | — | 0.261 | Q3 | 47.8% | |
| 2018 | — | — | 0.895 | Q1 | 81.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2073-4468
country
CHcoverage
2012-2025